Adam Robitel

Ask VT AI
View News Summary
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
  • Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
  • Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Adam Robitel